Kufe D - Search Results

1

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. Andreeff M, et al. Among authors: kufe d. Blood. 1992 Nov 15;80(10):2604-9. Blood. 1992. PMID: 1421378 Free article. Clinical Trial.

2

MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells.

Yin L, Wu Z, Avigan D, Rosenblatt J, Stone R, Kharbanda S, Kufe D. Yin L, et al. Among authors: kufe d. Blood. 2011 May 5;117(18):4863-70. doi: 10.1182/blood-2010-10-296632. Epub 2011 Mar 21. Blood. 2011. PMID: 21422470 Free PMC article.

3

Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites.

Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Stone RM, et al. Among authors: kufe dw. Blood. 1990 Sep 15;76(6):1225-32. Blood. 1990. PMID: 2144778 Free article.

4

Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Sariban E, Pettit GR, Kufe DW. Stone RM, et al. Among authors: kufe dw. Blood. 1988 Jul;72(1):208-13. Blood. 1988. PMID: 2455568 Free article.

5

Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Weber BL, Spriggs DR, Kufe DW. Stone RM, et al. Among authors: kufe dw. Blood. 1988 Aug;72(2):739-44. Blood. 1988. PMID: 3165300 Free article.

6

All-trans retinoic acid reverses phorbol ester resistance in a human myeloid leukemia cell line.

Yang KD, Mizobuchi T, Kharbanda SM, Datta R, Huberman E, Kufe DW, Stone RM. Yang KD, et al. Among authors: kufe dw. Blood. 1994 Jan 15;83(2):490-6. Blood. 1994. PMID: 8286746 Free article.

7

Recombinant human gamma interferon administered by continuous intravenous infusion in acute myelogenous leukemia and myelodysplastic syndromes.

Stone RM, Spriggs DR, Arthur KA, Mayer RJ, Griffin J, Kufe DW. Stone RM, et al. Among authors: kufe dw. Am J Clin Oncol. 1993 Apr;16(2):159-63. doi: 10.1097/00000421-199304000-00017. Am J Clin Oncol. 1993. PMID: 8452111 Clinical Trial.

8

CSFs in combination with cytosine arabinoside, an inhibitor of DNA synthesis: potential strategies for the treatment of myeloid disorders.

Brach M, Stone R, Kufe D. Brach M, et al. Among authors: kufe d. Biotechnol Ther. 1991;2(3-4):269-83. Biotechnol Ther. 1991. PMID: 1845130 Review.

9

A phase I study of intermittent continuous infusion high dose cytosine arabinoside for acute leukemia.

Stone RM, Spriggs DR, Dhawan RK, Arthur KA, Mayer RJ, Kufe DW. Stone RM, et al. Among authors: kufe dw. Leukemia. 1990 Dec;4(12):843-7. Leukemia. 1990. PMID: 2243507

10

MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.

Liu S, Yin L, Stroopinsky D, Rajabi H, Puissant A, Stegmaier K, Avigan D, Kharbanda S, Kufe D, Stone R. Liu S, et al. Among authors: kufe d. Blood. 2014 Jan 30;123(5):734-42. doi: 10.1182/blood-2013-04-493858. Epub 2013 Nov 26. Blood. 2014. PMID: 24282218 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

677 results

Search Page

Filters